Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects (Q40885346)

24 September 2017

Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects (English)

1 reference

24 September 2017

0 references

1 reference

1 reference

G Tybring

1

1 reference

24 September 2017

Y Böttiger

series ordinal

2

1 reference

24 September 2017

J Widén

series ordinal

3

1 reference

24 September 2017

L Bertilsson

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

Clinical Pharmacology & Therapeutics

24 September 2017

1 reference

24 September 2017

62

1 reference

24 September 2017

2

1 reference

24 September 2017

129-137

1 reference

https://scigraph.springernature.com/pub.10.1016/s0009-9236(97)90060-6

24 September 2017

0 references

cites work

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

The mechanism of action of the gastric acid secretion inhibitor omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Omeprazole: pharmacokinetics and metabolism in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

CYP2C19 genotype and phenotype determined by omeprazole in a Korean population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Resolution of the enantiomers of omeprazole and some of its analogues by liquid chromatography on a trisphenylcarbamoylcellulose-based stationary phase. The effect of the enantiomers of omeprazole on gastric glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Enantioselective high-performance liquid chromatographic determination of omeprazole in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Determination of omeprazole and metabolites in plasma and urine by liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Determination of R(+)- and S(-)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Direct determination of pantoprazole enantiomers in human serum by reversed-phase high-performance liquid chromatography using a cellulose-based chiral stationary phase and column-switching system as a sample cleanup procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990060-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(97)90060-6

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference